scholarly journals Association between Ischemic Electrocardiographic Changes during Acetylcholine Provocation Test and Long-Term Clinical Outcomes in Patients with Vasospastic Angina

2019 ◽  
Vol 34 (1) ◽  
pp. 1
Author(s):  
Sung Il Im ◽  
Seung-Woon Rha ◽  
Byoung Geol Choi ◽  
Jin Oh Na ◽  
Cheol Ung Choi ◽  
...  
Circulation ◽  
2014 ◽  
Vol 130 (suppl_2) ◽  
Author(s):  
Seung Woon Rha ◽  
Se-Whan Lee ◽  
Won-Yong Shin ◽  
Seung-Jin Lee ◽  
Dong-Kyu Jin ◽  
...  

Background: It is not known whether the presence of angiographic fixed coronary lesion (FCL) can negatively impact on long-term major clinical outcomes in vasospastic angina patients (pts) with myocardial bridge (MB). Methods: A total 5,882 patients (pts) underwent coronary angiography with acetylcholine (Ach) provocation test from Nov 2004 to Oct 2010. Among them, total 563 pts who had MB and documented significant coronary artery spasm (CAS) by Ach provocation test were enrolled. Study populations were categorized into two groups; the fixed coronary lesion (FCL) group (n=216) and the non-FCL group (n=347). Cumulative major clinical outcomes were compared between the two groups up to 3 years. Results: Baseline characteristics were similar between the two groups except the incidence of elderly, hypertension, diabetes, and dyslipidemia were higher in the FCL group. In univariate analysis, only the composite end-point consisted of cardiac death, de Novo percutaneous coronary intervention (PCI), myocardial infarction (MI), and cerebrovascular accident (CVA) was higher in FCL group (Table). However, in multivariate regression analysis, the incidences of cardiac death, PCI, MI, CVA, recurrent chest pain, and other composite end-points were similar between the two groups up to 3 years. Conclusions: In our study, the presence of angiographic fixed coronary lesion in vasospastic angina pts with MB was not a predictor of adverse long-term clinical outcomes.


2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
K Hao ◽  
J Takahashi ◽  
A Suda ◽  
K Sato ◽  
J Sugisawa ◽  
...  

Abstract Background Vasospastic angina (VSA), which is one of the important functional cardiac disorders, may also play a role in the pathogenesis of atherosclerosis. Conversely, organic coronary stenosis is also known as an independent predictor for poor clinical outcomes in VSA patients. Although VSA patients have a variable degree of organic coronary stenosis in clinical setting, the functional importance of organic stenosis in those patients remains to be elucidated. Purpose The aim of this study was to examine the clinical importance and prognostic impact of fractional flow reserve (FFR) in patients with VSA and organic coronary stenosis. Methods We enrolled 236 consecutive patients with suspected vasospastic angina who underwent acetylcholine provocation test for coronary spasm (M/F 148/88, 63.6±12.0 [SD] yrs.). Among them, 175 patients (74.1%) were diagnosed as having VSA, while the remaining non-VSA patients were regarded as controls (Group-C, n=61). We divided the VSA patients into 3 groups based on angiographical findings and FFR values; VSA with no organic stenosis (>50% luminal stenosis) (Group-N, n=110), organic stenosis and high FFR (≥0.80) (Group-H, FFR 0.87±0.05, n=36), and organic stenosis and low FFR (<0.80) (Group-L, FFR 0.71±0.07, n=29). We evaluated the incidence of major adverse cardiovascular events (MACE), including cardiovascular death (CVD), non-fatal myocardial infarction (MI), urgent percutaneous coronary intervention (PCI), and hospitalization due to unstable angina pectoris (UAP) during the median follow-up period of 656 days. Results The groups with organic stenosis (Groups H and L) were characterized by higher prevalence of diabetes mellitus (Group-C/N/H/L, 23.0/20.9/44.4/34.5%, P=0.03) and dyslipidemia (Group-C/N/H/L, 37.7/39.1/50.0/65.5%, P=0.03) as compared with Group-C. After provocation test, all VSA patients received calcium channel blockers (CCBs). In addition, 20 days (median) after provocation test, 26 patients (92.9%) in Group-L underwent elective PCI with coronary stents, while no patient underwent PCI in Groups N or H. The incidence of MACE during follow-up was significantly higher in Group-L (Group-C/N/H/L; 1.6/3.6/5.6/27.6%, log-rank P<0.001), whereas clinical outcomes were comparable among the remaining 3 groups (Figure). Importantly, all 8 patients with MACE in Group-L had poor outcomes (CVD/MI/urgent PCI/UAP; 2/1/3/2) despite complete revascularization and the prevention of coronary spasm with CCBs, indicating that they might be resistant to standard contemporary therapies. They were characterized by less frequent use of angiotensin convert enzyme inhibitor (0 vs. 47.6%, P=0.02) and higher prevalence of multi-vessel organic lesions (37.5 vs. 4.8%, P=0.052) compared with those without MACE. Figure 1 Conclusions These results provide the first evidence that evaluation of coronary functional abnormalities with FFR is useful for making therapeutic strategies in VSA patients with organic coronary stenosis.


2021 ◽  
Vol 36 (1) ◽  
pp. 124-134
Author(s):  
Sung Eun Kim ◽  
Sang-Ho Jo ◽  
Seung Hwan Han ◽  
Kwan Yong Lee ◽  
Sung Ho Her ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document